Global $12.7 Billion Pharmacogenomics Markets to 2026 with – GlobeNewswire

Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmacogenomics Market 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global market for pharmacogenomics should grow from $7.7 billion in 2021 to $12.7 billion by 2026 with a compound annual growth rate (CAGR) of 10.6% for the period of 2021-2026.

Report Scope:

This report provides an updated review of pharmacogenomics, including materials, equipment, and strategies, and identifies current and emerging applications for pharmacogenomic products.

The report delineates the current market status for pharmacogenomics, defines trends, and presents growth forecasts for the next five years. The pharmacogenomics market is analyzed based on the following segments: technology, product type, end-user, application, and region. In addition, technological issues, including key events and the latest developments, are discussed.

The analysis of current revenues for pharmacogenomics is followed by a detailed presentation of market growth trends, based on industry growth, technological trends, and regional trends.

Pharmacogenomics is a group of technologies focusing on the application of genomic testing to determine drug response. This relatively new field of life sciences, which combines biology, pharmacology and medicine to develop new drugs and optimize their dosage, is bringing numerous advantages in healthcare, including personalized medicine, therapies with high specificity, remedies for rare and hard-to-cure diseases, and treatments with reduced side effects.

The report has identified five main sectors in which pharmacogenomics finds current and potential applications: cardiovascular disease; neurological and psychiatric disorders; oncology; respiratory and inflammatory diseases; and health management and predictive medicine.

This study provides an updated review of pharmacogenomic technologies, including materials, equipment, strategies, and applications. It also offers a detailed market analysis for pharmacogenomics by segment (technology, product type, end-user, application, and region), describing technical aspects and trends that will affect future growth of this market.

Applications for oncology currently account for the largest share of the market. Within this segment, pharmacogenomic products are being used primarily for the treatment of breast, lung and blood cancer.

The Report Includes:

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Chapter 4 Technology

Chapter 5 Global Markets

Chapter 6 Global Industry Structure and Company Profiles

Chapter 7 Patent Analysis

For more information about this report visit https://www.researchandmarkets.com/r/fi4u16

See original here:
Global $12.7 Billion Pharmacogenomics Markets to 2026 with - GlobeNewswire